Avalon GloboCare Corp., a Delaware-based company, has entered into a significant securities purchase agreement with Brown Stone Capital Ltd., an accredited investor. Under the agreement, Avalon will issue and sell 121,200 shares of its common stock and pre-funded warrants for an additional 354,300 shares to the investor, totaling $475,500. The transaction, which closed on July 17, 2025, generated net proceeds of $450,500 for Avalon after deducting offering expenses. Additionally, Avalon and the investor have entered into a registration rights agreement, committing to register the shares and warrants under the Securities Act of 1933. Avalon aims to file the registration statement by September 26, 2025, and seeks SEC approval within thirty to seventy-five days, depending on the review process.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。